Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
Part of paid clinical trials in Valhalla, New York.
- Sponsor
- New York Medical College
- Study ID
- NCT07000019
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Aphasia Following Cerebral Infarction
- Hemiparesis After Stroke
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- CARAT: combined aphasia and robot-assisted arm therapy — BEHAVIORALParticipants will receive 18 sessions of robot-assisted arm therapy combined with a standardized picture-word verification therapy task with the goal of improving language and arm movements.
- Robot-assisted arm therapy — BEHAVIORALParticipants will receive 18 sessions of robot-assisted arm therapy with the goal of improving arm movements.
Study Details
The goal of this clinical trial is to learn if a program that combines language and arm treatment can improve language and movement problems in people with chronic stroke. The mains questions it aims to answer are: * To determine the extent to which this combined treatment can improve language. * To determine the extent to which the combined treatment can improve arm movements. Researchers will compare the effects of this combined treatment with treatment that targets arm movements alone.
Key Dates
- Start date
- Jun 30, 2025
- Status verified
- May 2025
- Primary completion
- Oct 31, 2027
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 28 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Combined aphasia and robot-assisted arm treatment
- Active Comparator: Robot-assisted arm treatment
Primary Outcome Measure
Philadelphia Naming Test [ Time Frame: Baseline to 1 week post-treatment ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Westchester Medical Center / New York Medical College | Valhalla | New York | 10595 | Cristina Falo, PhD Tomoko Kitago, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Valhalla, NY
Related Studies
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic AphasiaRecruiting · City University of New York · New York, New York